SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi and pan-Canadian alliance sign Sarclisa letter of intent

Sanofi and the pan-Canadian Pharmaceutical Alliance signed a letter of intent for Sarclisa (isatuximab), a step toward public access for newly diagnosed, transplant-ineligible multiple myeloma patients.

Related stories